Back to Search
Start Over
Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor–Positive Advanced Breast Cancer: A Phase 1b Clinical Trial.
- Source :
- JAMA Oncology; Feb2019, Vol. 5 Issue 2, pe184475-e184475, 1p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 23742437
- Volume :
- 5
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- JAMA Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 134730847
- Full Text :
- https://doi.org/10.1001/jamaoncol.2018.4475